GGrantIndex
Sort

39,280 grants matching leukemia

DCTD Cancer Diagnosis

$724,542
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA

Human PSC-based cortical organoid and assembloid systems integrating pericyte and microglial lineages and signals

$724,048
Lorenz P. Studer · Sloan-Kettering Inst Can Research · R01 · FY2024 · MH

Integrated Multi-Scale Analysis of Tumor and Host Response to Therapy

$723,484
Shan X. Wang · University Of Southern California · U54 · FY2012 · CA

Nuclear Receptor Functional Profiling in Metabolism and Disease

$723,430
Ronald M. Evans · Baylor College Of Medicine · U19 · FY2007 · DK

Recruitment of a translational researcher for leukemia

$723,425
Janis L Abkowitz · University Of Washington · P30 · FY2009 · CA

124I-NaI PET: Building block for precision medicine in metastatic thyroid cancer

$723,362
Steven M Larson · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Enhancing Treg Therapeutic Efficacy in GVHD

$722,503
Bruce R. Blazar · University Of Minnesota · R01 · FY2022 · HL

Immunobiology of Normal and Neoplastic Lymphocytes

$722,337
Warren S Pear · University Of Pennsylvania · T32 · FY2022 · CA

Cancer Mortality among Military Participants at U.S. Nuclear Weapons Tests

$722,003
John Dunning Boice · Vanderbilt University · U01 · FY2011 · CA

Mechanism and functional consequences of dietary lipids in lineage specification and tumor growth in oncohistone gliomas

$721,959
Nika N. Danial · Dana-Farber Cancer Inst · U01 · FY2024 · CA

Multiplex Epitope Editing to Enable Novel Immunotherapies for Acute Myeloid Leukemia

$721,888
Pietro Genovese · Boston Children'S Hospital · R01 · FY2025 · CA

PRE-AND POSTGRADUATE TRAINING IN MOLECULAR HEMATOLOGY

$721,795
J Evan Sadler · Washington University · T32 · FY2018 · HL

Attacking the Tumor Cell-Immune Milieu Interface to Overcome Richter's Transformation

$721,723
Lili Wang · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA

Protein Structure, Stability, and Amyloid Formation

$721,651
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

CMVPepVax to Protect HCT Recipients from Cytomegalovirus Infection

$721,537
Don J Diamond · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA

Functional and Mechanistic Study of Histone Crotonylation in Hematological Malignancies

$721,245
Charles David Allis · Rockefeller University · R01 · FY2016 · CA

Personalized vaccine for patients with AML

$721,179
David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2018 · CA

Personalized vaccine for patients with AML

$721,179
David E Avigan · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA

Integrated Multi-Scale Analysis of Tumor and Host Response to Therapy

$721,122
Shan X. Wang · University Of Southern California · U54 · FY2011 · CA

Improving risk allocation and developing novel therapies for children with T-ALL and T-LL

$721,069
David T. Teachey · Children'S Hosp Of Philadelphia · R01 · FY2024 · CA

Development of P2Y Receptor Ligands

$721,055
Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK

Impact of Celecoxib and Inflammation on Survival in Stage III Colon Cancer

$720,713
Charles S Fuchs · Dana-Farber Cancer Inst · R01 · FY2014 · CA

Personalized precision dosing of biologic therapies in oncology

$720,363
Bradley T Messmer · Abreos Biosciences, Inc. · R44 · FY2018 · CA

ITSC for Leukemia: Novel Molecular strategies for NCTN "Individualized" Therapies

$719,943
John C Byrd · Ohio State University · UG1 · FY2020 · CA

Pulmonary Immune Regulation of Lung Injury after Pediatric Hematopoietic Cell Transplant

$719,882
Matthew Scott Zinter · University Of California, San Francisco · R01 · FY2025 · HL